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The widespread contamination of foodstuffs and beverages by mycotoxins, such as
ochratoxin A (OTA), has made the monitoring of human contamination levels essential.
By using a sensitive, accurate and speedy method that combines extraction with 5%
NaHCO3, immunoaffinity column clean-up and HPLC with fluorescence detection, the
human exposure to OTA through urine analysis can be monitored. This method is less
invasive than blood monitoring and has the potential to be a good marker of human
exposure. The limit of quantification of the method was 0.007ng/mL of urine, with
recoveries of OTA, from urine samples spiked at levels between 0.02 and 0.1 ng/mL, higher
than 91% with RSD lower than 15.5%.
This study evaluated OTA contamination levels in human urine sample fractions,
collected in the morning and afternoon, in two populations, one from Coimbra city, in
Portugal, and another from the Valencian community, in Spain. In the Coimbra
population, 60 samples from 30 healthy individuals were analyzed, levels of OTA in 13
morning samples and 14 afternoon samples having been detected, with concentrations
ranging from 0.011 to 0.208 and 0.008 to 0.11ng/mL respectively. In the Valencia
population, 62 samples from 31 healthy individuals were analyzed, with OTA being
detected in 25 morning samples and 26 afternoon samples. The concentrations varied
between 0.007 and 0.124ng/mL in the morning samples, and 0.008 and 0.089 ng/mL in
the afternoon samples. Significant differences were found between the morning levels of
OTA from both populations (P ¼ 0.033). For afternoon samples, significant differences
were not found, P value ¼ 0.163.
& 2008 Elsevier Ltd. All rights reserved.All rights reserved.
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Ochratoxin A (OTA) is a secondary fungal metabolite
produced by several Aspergillus and Penicillium species,
mainly Aspergillus alutaceus in warmer and tropical
climates, and Penicillium verrucosum in temperate climates
(Moreno Guillamont et al., 2005). Due to the ubiquitous
nature of these fungal species, OTA is one of the most
prevalent human contaminants in the food chain. Its
presence, in the human body, is due to the ingestion of
small quantities present in a variety of foodstuffs and
beverages. Namely, in Portugal and Spain, due to high
consumption of cereals and cereal products, spices, rice,
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2007; Gonza´lez et al., 2006; Gonza´lez-Osnaya et al.,
2007, 2008; Burdaspal and Legarda, 2007; Blesa
et al., 2006; Pena et al., 2005; Juan et al., 2006, 2007,
2008; Lino et al., 2006; Visconti et al., 2000; Skaug
et al., 2001) this fact is also verified. This mycotoxin
is also detected in meat products due to transmission
into muscle, kidney, liver and blood from animals fed
with natural contaminants (Moreno Guillamont et al.,
2005).
Toxicological studies have demonstrated OTA’s
nephrotoxic, hepatotoxic, immunotoxic, teratogenic and
carcinogenic activity towards several animal species,
having been classified by the International Agency for
Research on Cancer (IARC) as a possible carcinogen to
humans (Group 2B) (IARC, 1993). This mycotoxin is also
suspected of being involved in the etiology of Balkan
endemic nephropathy and is associated with the occur-
rence of urinary tract tumors (Pfohl-Leszkowicz et al.,
2002).
Human exposure to OTA has clearly been demon-
strated in studies performed in blood, urine and breast
milk samples (Dinis et al., 2007; Lino et al., 2008; Pena
et al., 2006; Skaug et al., 2001). This exposure is further
enhanced due to OTA’s unusually long serum half-life, as a
result of its ability to bind to plasma protein, its
enterohepatic circulation and its re-absorption from urine
(Studer-Rohr et al., 2000).
OTA excretion from the human body is mainly done by
elimination through urine (Li et al., 1997). However, the
concentration levels of this mycotoxin in urine are very
low, therefore a sensitive and accurate method of detec-
tion is required to monitor OTA contamination. Due to
recent developments in analytical methodology, urinary
monitoring is nowmore feasible, and has the advantage of
being less invasive than blood monitoring, having the
potential to be a good marker of human exposure to this
mycotoxin (Gilbert et al., 2001). However, data in the
frequency and concentration of OTA in human urine are
still scarce.
Only a few studies were carried out in Europe (Domijan
et al., 2003; Petkova-Bocharova et al., 2003; Pascale
and Visconti, 2000; Pena et al., 2006; Fazekas et al.,
2005; Gilbert et al., 2001), Africa (Jonsyn-Ellis, 1999,
2000) and Asia (Castegnaro et al., 1990) reporting the
presence of OTA in urine human samples. These studies
have shown that OTA occurs in urine in different mean
concentrations, oscillating between 0.027ng/mL in Portu-
gal (Pena et al., 2006) and 2.39ng/mL in Croatia (Domijan
et al., 2003).
The most widely employed analytical methodology
for OTA quantification is liquid chromatography (LC)
with fluorescence or mass spectrometry detection
coupled with immunoaffinity column (IAC) clean-up.
Since OTA has good fluorescence properties, it can be
accurately and sensitively determined with fluorescence
detection.
The present study is the first approach to follow-up
OTA levels and frequency of detection in urine samples
collected in the morning and afternoon, from samples of
healthy inhabitants from two cities, Coimbra (Portugal)and Valencia (Spain), in order to evaluate the differences
between OTA levels in the more concentrated morning
urine samples and the afternoon urine samples, and to
evaluate the populations’ contamination.2. Experimental
2.1. Solvents and materials
Acetonitrile, toluene and methanol (HPLC grade) were
purchased from Carlo Erba (Milan, Italy). Acetic acid,
hydrochloric acid, sodium sulfate anhydrous, sodium
hydroxide, sodium hydrogen carbonate, sodium chloride,
potassium chloride, potassium dihydrogen-phosphate and
anhydrous disodium hydrogen-phosphate were obtained
from Merck (Darmstadt, Germany). OTA and boron
trifluoride 14% methanolic solution were purchased from
Sigma Chemicals Co. (St. Louis, USA).
OTA stock solution (250mg/mL) was prepared by
dissolution of the solid standard in 4mL toluene–
acetic acid (99:1), and stored at 20 1C. An intermediate
standard solution (10 mg/mL) was prepared diluting
1mL of the stock standard solution with 25mL tolue-
ne–acetic acid (99:1). The actual concentration of the
OTA was calculated using an ultraviolet light spectro-
photometer set at 333nm (e ¼ 5440) (Entwisle et al.,
2000).
For the fortification assays, a standard solution
(1 mg/mL) was prepared in toluene–acetic acid (99:1). To
derive the calibration curve, a standard solution was
prepared evaporating 100mL of the intermediate standard
solution until dryness, under a gentle stream of nitrogen.
The residue was then diluted in 10mL of mobile phase, a
mixture consisting of acetonitrile–water–acetic acid
(49.5:49.5:1 v/v/v). This working standard solution was
then diluted accordingly to prepare the external calibra-
tion curve (1, 2, 5, 10ng/mL).
The phosphate buffer saline (PBS) solution was
prepared from potassium chloride (0.2 g), potassium
dihydrogen-phosphate (0.2 g), anhydrous disodium
hydrogen-phosphate (1.2 g) and sodium chloride (8 g),
added to distilled water (900mL). After dissolution, the
pH was adjusted to 7.4, with 0.1M HCl or 0.1M NaOH as
appropriate. The solution was made to 1 L.
The water used was purified by distillation and passage
through a Milli Q system (Millipore, Bedford, MA). All
chromatographic solvents and water were filtered through
a 0.20 mm membrane filter (+ 50mm Schleicher &
Schuell, Germany) under vacuum and degassed for
15min in an ultrasonic bath.
Clean-up was performed using IACs OchraTestTM
(Vicam/Watertown, USA). A vortex mixer Retsh (Haan,
Germany) and an ultrasonic bath Sonorex RK 100 (Berlin,
Germany) were also used.
Amber glassware was used to prevent light deteriora-
tion of the mycotoxin. Decontamination of the glassware
was performed using a sodium hypochlorite solution. It
was then acid-washed by immersing the glassware in a
solution of 4mL/L H2SO4, followed by washing to neutral
pH by rinsing with distilled water.
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Table 1
Accuracy and inter- and intra-assay validation results (n ¼ 3)
Fortification
level (ng/mL)
Recovery
mean (%)
RSD intra-
daya (%)
RSD inter-
dayb (%)
0.02 91.9 7.9 15.4
0.05 91.9 5.1 12.5
0.1 96.7 4.8 15.2
a Repeatability based on three replicates at 0.02, 0.05 and 0.1 ng/mL
within the same day.
b Three days’ repeatability based on the analysis at 0.02, 0.05 and
0.1 ng/mLday.
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The HPLC system consisted of a Gilson pump, model
307 (Gilson Medical Electronics, Villiers-le-Bel France), a
Rheodyne injector, model 7125 (Cotati, CA, USA) and a
Perkin-Elmer spectrofluorimeter, model LS45 (Perkin-
Elmer, Beaconsfield, UK), operated at an excitation
wavelength of 333nm and an emission wavelength of
477nm. The spectral bandwidth was 10nm for both
excitation and emission. The results were recorded on a
Hewlett-Packard integrator, model 3390A (Hewlett-Pack-
ard, Philadelphia, USA).
A C18 Nucleosil 5 mm 120 A˚ (4.030mm i.d.) guard
column and a C18 Nucleosil 5mm 100 A˚ (4.6250mm i.d.)
column were used.
The mobile phase consisted of a mixture of acetoni-
trile–water–acetic acid (49.5:49.5:1 v/v/v) maintained at
a flow rate of 1mL/min, and at room temperature.
For the fluorescence detection of OTA, the emission
and excitation wavelengths were optimized by obtaining
the spectrum of OTA standard solution in HPLC mobile
phase. At an excitation wavelength of 333nm, the
maximum emission wavelength was found to occur at
477nm.
Isocratic analysis under the conditions described above
allowed the elution of OTA with good resolution.
2.3. Extraction and clean-up
Extraction and clean-up were performed according to
the method developed by Pena et al. (2006). Briefly,
human urine diluted with a solution of NaHCO3 and
filtered was cleaned up through the OchraTestTM IAC, and
eluted with methanol. The eluted extract, after evapora-
tion to dryness under a gentle stream of nitrogen at 50 1C,
was dissolved in 120mL of the HPLC mobile phase, instead
of 150mL of the original method in order to improve the
LOQ. Finally, 50mL was injected into the HPLC system.
2.4. Sampling
In the city of Coimbra were collected 30 morning urine
samples and 30 afternoon urine samples, from 30 healthy
resident individuals. From the 30 participants involved,
57% (n ¼ 17) were female, aged 15–55 years old, and 43%
(n ¼ 13) were male, aged 22–67 years old.
The samples from the Valencian community were
collected from 31 healthy individuals, 31 being from the
morning portion of urine and 31 from the afternoon
portion. Of the participants involved, 68% (n ¼ 21) were
female, aged 24–53, and 32% (n ¼ 10) were male, aged
between 18 and 51.
Urine samples were collected between September
2005 and February 2006 in Coimbra, and in April 2005
at Valencia.
After collection, the samples were stored at 20 1C
until analysis.
All volunteers were asked to fill a rapid questionnaire
about age, gender, height and weight. They were clearly
informed and gave their written permission.2.5. Chemical confirmation of OTA by methyl ester
formation
In order to confirm the presence of OTA in the positive
samples, a chemical confirmation was performed using
the Castegnaro et al. (1990) method. This method involves
the formation of an OTA methyl ester using boron
trifluoride. In this procedure, extracts from the positive
samples were evaporated to dryness and 150 mL of boron
trifluoride 14% methanolic solution was added. The
mixture was then left at 60 1C for 10min, after which it
was evaporated under a gentle stream of nitrogen. The
residue was then dissolved in 150mL of mobile phase and
50mL was injected into the HPLC system.2.6. Statistical analysis
Database management and statistical analysis were
performed using SPSS (Statistical Package for the Social
Science), Microsoft version 10.0. The Pearson chi-square
test was used to test for significant differences between
groups. Pp0.05 (two-tailed) was considered to be statis-
tically significant. For statistical analysis, if the concentra-
tion was below the limit of quantification (LOQ) it was
set to 50% of that limit when the mean and SD were
calculated.3. Results
The calibration curve was obtained using the linear
least-squares regression procedure of the peak area versus
the concentration. The linearity using LC–FD for OTA, in
the working standard solutions at three determinations of
four concentration levels, between 1 and 10ng/mL (1.0,
2.0, 5.0 and 10.0 ng/mL), was good as shown by the
correlation coefficient (r2) determined, 0.998.
The proposed analytical method was optimized in
order to obtain good accuracy and precision. The accuracy
of the method was evaluated by analyzing spiked OTA-free
sample, at three different levels, 0.02, 0.05 and 0.1ng/mL,
with mean recoveries ranging from 91.9% to 96.7%. The
intra-day repeatability varied between 4.8% and 7.9%, and
the inter-day repeatability between 12.5% and 15.4% for the
above-mentioned fortification levels (Table 1).
The LOQ of OTA in urine was 0.007ng/mL, determined
at a signal-to-noise ratio of approximately 10:1.
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Fig. 1. Chromatograms of ochratoxin A (OTA) standard solution (a) (5 ng/
mL), a fortified sample (b) (0.05 ng/mL), a morning positive sample (c)
(0.015ng/mL of urine) and an afternoon positive sample (d) (0.017ng/mL
of urine). Both the morning and afternoon positive samples are from the
same individual.
R. Manique et al. / Toxicon 51 (2008) 1281–12871284Fig. 1 shows representative LC spectrofluorimetric
chromatograms obtained from an OTA standard solution,
from one fortified urine sample, one positive morning
sample and one afternoon sample.
Using the above-described methodology, 60 samples of
human urine, from 30 healthy individuals living in the
Portuguese city of Coimbra, were analyzed. Two samples
were collected from each individual in the same day, one
in the morning and one in the afternoon. OTA was
detected in 13 of the morning samples (43.3%), with
concentrations ranging from 0.011 to 0.208ng/mL, and in
14 of the afternoon samples (46.7%), with concentrations
ranging from 0.008 to 0.11ng/mL. The mean concentra-
tions and standard deviation in the morning and after-
noon samples were 0.01970.041 and 0.01870.027ng/mL,
respectively. Significant differences were found between
the morning and afternoon OTA levels, with P ¼ 0.000
(Table 2).
Comparing the data by gender, OTA was detected in
53.8% of the male morning samples and in 61.5% of the
afternoon samples, with concentrations ranging from
0.015 to 0.208ng/mL in the morning samples, and 0.008
and 0.110ng/mL in the afternoon. The mean concentration
and standard deviation were 0.02670.056 and 0.0237
0.031ng/mL for the morning and afternoon samples,
respectively. In the female samples, OTA was detected in
35.3% of both the morning and afternoon samples, with
concentrations ranging from 0.011 to 0.093ng/mL in the
morning, and 0.014 to 0.079ng/mL in the afternoon. The
mean concentrations and standard deviation were
0.01370.025ng/mL for the morning female samples and
0.01470.024ng/mL for the afternoon samples. Significant
differences were not found between females and males in
the morning samples (P ¼ 0.168) or in the afternoon
samples, with a P value of 0.279 (Table 3).
The same method and conditions were used to analyze
the 62 samples of human urine collected from 31 healthy
individuals living in the Spanish city of Valencia. OTA was
present in 25 (80.6%) of the morning samples and 26 of
the afternoon samples (83.9%), in concentrations ranging
from 0.007 to 0.124ng/mL in the morning and 0.008 to
0.089ng/mL in the afternoon. The mean concentrations
and standard deviation were 0.03270.031 and
0.02870.019ng/mL in the morning and afternoon sam-
ples, respectively. Significant differences were found
between the morning and afternoon OTA levels, with
P ¼ 0.002 (Table 2).
Comparing the frequency of detection and OTA levels
by gender, it was observed that, in the female urine
samples, OTA was present in 80.9% of the morning
samples, and in 85.7% of the afternoon samples, with
concentrations varying from 0.007 to 0.114ng/mL and
from 0.008 to 0.075ng/mL in the morning and afternoon
samples, respectively. The mean concentration and stan-
dard deviation for the morning samples and afternoon
samples were 0.03370.031 and 0.02770.021ng/mL,
respectively.
In the male urine samples, OTA was detected in 80% of
both the morning and afternoon samples, with concentra-
tions ranging from 0.01 to 0.124ng/mL in the morning
and 0.007 to 0.089ng/mL in the afternoon. The mean
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and 0.03170.028ng/mL for the same samples, respec-
tively. Moreover, the mean concentration of morning
female samples was higher than that of male samples,
0.033 versus 0.029ng/mL, without significant differences
(P ¼ 0.466). An opposite situation was observed for the
afternoon samples, 0.031ng/mL for male samples versus
0.027ng/mL for female samples. Significant differences
were not found (P ¼ 0.134) (Table 3).
When comparing the results from both cities it was
shown that the Spanish city of Valencia had a higher
frequency of detection and a higher OTA mean concentra-
tion, in both the morning and afternoon samples. How-
ever, significant differences were only found in the
morning samples, P ¼ 0.033. In the afternoon samples,
no differences were found (P ¼ 0.163).
4. Discussion
This study revealed that the frequency of detection in
the Coimbra population is higher than in the Sierra Leone
population, about 24–25% (Jonsyn-Ellis, 1999, 2000),
similar to that from India, 40% (Castegnaro et al., 1990),
and lower than Italy (Pascale and Visconti, 2000), Hungary
(Fazekas et al., 2005), the UK (Gilbert et al., 2001), Bulgaria
(Petkova-Bocharova et al., 2003) and Croatia (Domijan
et al., 2003) populations, with 58%, 60%, 92%, 87–92% and
94%, respectively. A similar situation was observed inTable 2
Mean, standard deviation, range (ng/mL) and frequency (%) of OTA in
morning (M) and afternoon (A) urine samples from Coimbra and
Valencia
Samples Frequency
(%)
Range (ng/
mL)
Mean7RSD
(ng/mL)
P value
Coimbra Ma,b 43.3 0.011–0.208 0.01970.041 0.000a
Coimbra Aa,c 46.7 0.008–0.110 0.01870.027 0.002d
Valencia Md,b 80.6 0.007–0.124 0.03270.031 0.033b
Valencia Ad,c 83.9 0.008–0.089 0.02870.019 0.163c
a Coimbra: morning versus afternoon.
b Morning: Coimbra versus Valencia.
c Afternoon: Coimbra versus Valencia.
d Valencia: morning versus afternoon.
Table 3
Mean, standard deviation, range (ng/mL) and frequency (%) of OTA in female
Coimbra and Valencia
Gendre-city Frequency (%) Range (n
M-Coimbra-MORa 53.8 0.015–0
W-Coimbra-MORa 35.3 0.011–0
M-Valencia-MORb 80.0 0.01–0
W-Valencia-MORb 80.9 0.007–0
M-Coimbra-AFTc 61.5 0.008–0
W-Coimbra-AFTc 35.3 0.014–0
M-Valencia-AFTd 80.0 0.007–0
W-Valencia-AFTd 85.7 0.008–0studies conducted in the Coimbra population in 2005,
with 70% (Pena et al., 2006). The Valencian population
revealed frequencies of detection similar to those found in
the Belia Izvor population at Bulgaria, 87.3%, and lower
than Gorno Peshtene at Bulgaria (Petkova-Bocharova
et al., 2003), 92%, and in Croatia, 94% (Domijan et al.,
2003) (Table 4).
Comparing our results, in terms of contamination
levels determined, with other studies from different
populations, the concentrations found in the Coimbra
population, 0.01970.041ng/mL, are higher than mean
concentrations in Hungary, 0.013ng/mL (Fazekas et al.,
2005), lower than those found in the Coimbra population
in 2005, 0.02770.004ng/mL (Pena et al., 2006), in
Bulgaria populations, 0.050870.044 and 0.16870.111ng/
mL (Petkova-Bocharova et al., 2003) and in Croatia,
2.3971.29ng/mL (Domijan et al., 2003). Regarding the
results from the Valencian community, 0.0370.031ng/
mL, it is observed that they are similar to those found in
the Coimbra population in 2005 (Pena et al., 2006), lower
than those from different populations in Europe (Petkova-
Bocharova et al., 2003; Domijan et al., 2003) and higher
than the Hungarian population (Fazekas et al., 2005)
(Table 4).
Regarding the OTA ranges in urine for both popula-
tions, 0.008–0.208ng/mL in Coimbra and 0.007–0.124ng/
mL in Valencia, they are similar to those found in some
European countries such as Italy (Pascale and Visconti,
2000) and the UK (Gilbert et al., 2001). However, for most
countries a great variation in the range of OTA levels is
observed (Table 4).
Previous studies about OTA serum levels in healthy
populations or nephropathic patients (Lino et al., 2008;
Jimenez et al., 1998; Dinis et al., 2007) clearly show the
exposure of Portuguese and Spanish populations to this
mycotoxin. This is corroborated with the presence of OTA
in Spanish and Portuguese foodstuffs such as cereals and
cereal products, rice, dried fruits, milk and wine (Bascara´n
et al., 2007; Gonza´lez et al., 2006; Gonza´lez-Osnaya et al.,
2007, 2008; Burdaspal and Legarda, 2007; Blesa et al.,
2006; Pena et al., 2005; Juan et al., 2006, 2007, 2008).
Regional differences in OTA levels in biological fluids in
different populations may be related to different situa-
tions. Factors such as climatic conditions of the different
areas, Coimbra and Valencia, and probably the ingestion of(W) and male (M) morning (MOR) and afternoon (AFT) samples from
g/mL) Mean7RSD (ng/mL) P value
.021 0.02670.056 0.168a
.093 0.01370.025
.124 0.02970.036 0.466b
.114 0.03370.031
.110 0.02370.031 0.279c
.079 0.01470.024
.089 0.03170.028 0.134d
.075 0.02770.021
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Table 4
Ochratoxin A in human urine samples from different countries
Country % Detection Range (ng/mL) Mean (ng/mL) Reference
Bulgaria Petkova-Bocharova et al. (2003)
Gorno Peshtene (n ¼ 25) 92 0.010–0.33 0.050870.044
Beli Izvor (n ¼ 55) 87.3 0.010–1.910 0.16870.111
Croatia—eastern (n ¼ 35) 94 0.99–5.22 2.3971.29 Domijan et al. (2003)
Italy (n ¼ 38) 58 0.012–0.046 – Pascale and Visconti (2000)
India (n ¼ 152) 40 0.005–0.03 – Castegnaro et al. (1990)
Hungary (n ¼ 88) 61 0.0006–0.65 – Fazekas et al. (2005)
UK (n ¼ 50) 92 0.01–0.058 0.013 Gilbert et al. (2001)
Sierra Leone Jonsyn-Ellis (2000)
Dry season (n ¼ 244) 25.8 0.07–148.0
Rainy season (n ¼ 190) 24.7 0.6–72.2
Sierra Leone (n ¼ 54) 24 0.3–26.6 Jonsyn-Ellis (1999)
Portugal—Coimbra (n ¼ 60) 70 0.021–0.105 0.02770.004 Pena et al. (2006)
Present study
Portugal—Coimbra (n ¼ 30) 43.3 0.011–0.208 0.01970.041
Spain—Valencia (n ¼ 31) 80.6 0.007–0.124 0.0370.031
R. Manique et al. / Toxicon 51 (2008) 1281–12871286item foods with deficient procedures of conservation have
great importance. Different consumption habits, con-
sumption of alcoholic beverages, such as beer and wine,
and regional food intake patterns may contribute to the
difference in OTA concentrations (Lino et al., 2008).
Regional differences have also been observed in different
countries, as previously described (Table 4). The climate
may also be responsible for fluctuations in human
exposure, because the consumed food may be contami-
nated at different levels under different climatic condi-
tions (Jimenez et al., 1998). Climatic factors such as
temperature, humidity, O2 versus CO2 ratio as well as
social conditions and behavior as methods of food
preservation, and environmental pollution are all accu-
mulating factors that enhance proliferation of toxigenic
fungi (Wafa et al., 1998).
In spite of a study in the UK that concluded that OTA in
urine is a better indicator of its consumption than OTA in
plasma (Gilbert et al., 2001), Studer-Rohr et al. (2000)
showed that in Swiss human volunteers dosed with
tritiated OTA, only 42–54% of the radioactivity that
appeared in urine corresponded to unchanged OTA,
showing that further work needs to be done to verify if
urine concentrations are a short- or a long-term indicator
of exposure to this mycotoxin.5. Conclusions
This study showed that there are significant differences
between OTA urine levels in morning and afternoon
samples from both analyzed populations. It was also
demonstrated that frequency of detection and mean
concentration are higher in the Valencian community
than in the Coimbra population.
It was also observed that between genders, significant
differences were not found, in both morning and after-
noon samples, in the same analyzed population.In addition, the data of this study demonstrated that
both populations are less exposed to OTA than the
generality of the European countries.
The widespread contamination of the world popula-
tion, due to ingestion of OTA-contaminated commodities,
is a reality. Therefore it is necessary to continue to
monitor OTA levels, in order to evaluate the exposure of
the populations to this toxin.Acknowledgments
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